Ohio State University - OSUMC - Wexner Medical Center
Welcome,         Profile    Billing    Logout  
 5 Trials 
13 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quick, Allison
NCT03614949: SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Active, not recruiting
2
21
US
Stereotactic body radiation therapy (SBRT), radiotherapy, Atezolizumab, Tecentriq®, immunotherapy
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic
10/25
10/26
NCT03307044: Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Completed
N/A
66
US
Laser Therapy, Therapy, Laser, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Breast Carcinoma, Cancer Survivor, Cervical Carcinoma, Dyspareunia, Vaginal Dryness
12/18
05/22
GEORGIA, NCT04713618: Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Active, not recruiting
N/A
89
US
Pelvic Examination, internal examination, Pelvic Exam, Survey, Survey Instrument
Ohio State University Comprehensive Cancer Center
Anal Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Malignant Pelvic Neoplasm, Rectal Carcinoma, Vaginal Carcinoma, Vulvar Carcinoma
10/23
12/26
NCT04269837: Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer

Completed
N/A
4
US
Counseling, Counseling Intervention, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Malignant Female Reproductive System Neoplasm, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8, Stage I Vaginal Cancer AJCC v8, Stage I Vulvar Cancer AJCC v8, Stage IA Cervical Cancer AJCC v8, Stage IA Uterine Corpus Cancer AJCC v8, Stage IA Vaginal Cancer AJCC v8, Stage IA Vulvar Cancer AJCC v8, Stage IA1 Cervical Cancer AJCC v8, Stage IA2 Cervical Cancer AJCC v8, Stage IB Cervical Cancer AJCC v8, Stage IB Uterine Corpus Cancer AJCC v8, Stage IB Vaginal Cancer AJCC v8, Stage IB Vulvar Cancer AJCC v8, Stage IB1 Cervical Cancer AJCC v8, Stage IB2 Cervical Cancer AJCC v8, Stage II Cervical Cancer AJCC v8, Stage II Uterine Corpus Cancer AJCC v8, Stage II Vaginal Cancer AJCC v8, Stage II Vulvar Cancer AJCC v8, Stage IIA Cervical Cancer AJCC v8, Stage IIA Vaginal Cancer AJCC v8, Stage IIA1 Cervical Cancer AJCC v8, Stage IIA2 Cervical Cancer AJCC v8, Stage IIB Cervical Cancer AJCC v8, Stage IIB Vaginal Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Uterine Corpus Cancer AJCC v8, Stage III Vaginal Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Cervical Cancer AJCC v8, Stage IIIA Uterine Corpus Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8, Stage IIIB Cervical Cancer AJCC v8, Stage IIIB Uterine Corpus Cancer AJCC v8, Stage IIIB Vulvar Cancer AJCC v8, Stage IIIC Uterine Corpus Cancer AJCC v8, Stage IIIC Vulvar Cancer AJCC v8, Stage IIIC1 Uterine Corpus Cancer AJCC v8, Stage IIIC2 Uterine Corpus Cancer AJCC v8, Stage IVA Cervical Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVA Vaginal Cancer AJCC v8, Stage IVA Vulvar Cancer AJCC v8
04/23
04/23
Ahmed, Kamran
NCT05115474: Study of Screening Brain MRIs in Stage IV Breast Cancer

Active, not recruiting
2
118
US
Magnetic Resonance Imaging, MRI
H. Lee Moffitt Cancer Center and Research Institute, Florida Breast Cancer Foundation
Triple Negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer
06/25
06/26
NCT06833502: Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

Recruiting
2
120
US
CT Scan
H. Lee Moffitt Cancer Center and Research Institute, Florida Breast Cancer Foundation
Breast Cancer, Node-positive Breast Cancer
08/26
08/26
NCT03614949: SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Active, not recruiting
2
21
US
Stereotactic body radiation therapy (SBRT), radiotherapy, Atezolizumab, Tecentriq®, immunotherapy
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic
10/25
10/26
NCT05528133: Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Recruiting
2
86
US
Genomically Guided Radiation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Triple Negative Breast Cancer
01/26
01/27
NCT04588545: Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Recruiting
1/2
39
US
Radiation Therapy, Pertuzumab, Trastuzumab
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease
07/25
07/25
MCC-21676, NCT06238921: Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

Recruiting
1/2
31
US
Stereotactic Radiation, Zimberelimab, Sacituzumab govitecan, Trodelvy
H. Lee Moffitt Cancer Center and Research Institute, Gilead Sciences
Breast Cancer, Triple Negative Breast Cancer
02/27
02/27
MCC-20899, NCT04923542: Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

Recruiting
1/2
31
US
Stereotactic Radiosurgery (SRS), Abemaciclib, Verzenio, Ramiven, Endocrine therapy, hormone therapy
H. Lee Moffitt Cancer Center and Research Institute, Eli Lilly and Company
Brain Metastases, HR+ Metastatic Breast Cancer
03/25
03/26
CA209-8NK, NCT03807765: Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

Active, not recruiting
1
14
US
Nivolumab, Opdivo, Stereotactic Radiosurgery
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb
Metastatic Breast Cancer, Brain Metastases
09/20
09/25
MIND-P, NCT04647474: Mental Wellbeing and Quality of Life in Prostate Cancer

Completed
N/A
300
Europe
King's College London, King's College Hospital NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Imperial College Healthcare NHS Trust, Medway NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Surrey and Sussex Healthcare NHS Trust, Bedfordshire Hospitals NHS Foundation Trust
Prostate Cancer
03/23
03/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quick, Allison
NCT03614949: SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Active, not recruiting
2
21
US
Stereotactic body radiation therapy (SBRT), radiotherapy, Atezolizumab, Tecentriq®, immunotherapy
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic
10/25
10/26
NCT03307044: Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Completed
N/A
66
US
Laser Therapy, Therapy, Laser, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Breast Carcinoma, Cancer Survivor, Cervical Carcinoma, Dyspareunia, Vaginal Dryness
12/18
05/22
GEORGIA, NCT04713618: Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Active, not recruiting
N/A
89
US
Pelvic Examination, internal examination, Pelvic Exam, Survey, Survey Instrument
Ohio State University Comprehensive Cancer Center
Anal Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Malignant Pelvic Neoplasm, Rectal Carcinoma, Vaginal Carcinoma, Vulvar Carcinoma
10/23
12/26
NCT04269837: Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer

Completed
N/A
4
US
Counseling, Counseling Intervention, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Ohio State University Comprehensive Cancer Center
Malignant Female Reproductive System Neoplasm, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8, Stage I Vaginal Cancer AJCC v8, Stage I Vulvar Cancer AJCC v8, Stage IA Cervical Cancer AJCC v8, Stage IA Uterine Corpus Cancer AJCC v8, Stage IA Vaginal Cancer AJCC v8, Stage IA Vulvar Cancer AJCC v8, Stage IA1 Cervical Cancer AJCC v8, Stage IA2 Cervical Cancer AJCC v8, Stage IB Cervical Cancer AJCC v8, Stage IB Uterine Corpus Cancer AJCC v8, Stage IB Vaginal Cancer AJCC v8, Stage IB Vulvar Cancer AJCC v8, Stage IB1 Cervical Cancer AJCC v8, Stage IB2 Cervical Cancer AJCC v8, Stage II Cervical Cancer AJCC v8, Stage II Uterine Corpus Cancer AJCC v8, Stage II Vaginal Cancer AJCC v8, Stage II Vulvar Cancer AJCC v8, Stage IIA Cervical Cancer AJCC v8, Stage IIA Vaginal Cancer AJCC v8, Stage IIA1 Cervical Cancer AJCC v8, Stage IIA2 Cervical Cancer AJCC v8, Stage IIB Cervical Cancer AJCC v8, Stage IIB Vaginal Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Uterine Corpus Cancer AJCC v8, Stage III Vaginal Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Cervical Cancer AJCC v8, Stage IIIA Uterine Corpus Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8, Stage IIIB Cervical Cancer AJCC v8, Stage IIIB Uterine Corpus Cancer AJCC v8, Stage IIIB Vulvar Cancer AJCC v8, Stage IIIC Uterine Corpus Cancer AJCC v8, Stage IIIC Vulvar Cancer AJCC v8, Stage IIIC1 Uterine Corpus Cancer AJCC v8, Stage IIIC2 Uterine Corpus Cancer AJCC v8, Stage IVA Cervical Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVA Vaginal Cancer AJCC v8, Stage IVA Vulvar Cancer AJCC v8
04/23
04/23
Ahmed, Kamran
NCT05115474: Study of Screening Brain MRIs in Stage IV Breast Cancer

Active, not recruiting
2
118
US
Magnetic Resonance Imaging, MRI
H. Lee Moffitt Cancer Center and Research Institute, Florida Breast Cancer Foundation
Triple Negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer
06/25
06/26
NCT06833502: Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

Recruiting
2
120
US
CT Scan
H. Lee Moffitt Cancer Center and Research Institute, Florida Breast Cancer Foundation
Breast Cancer, Node-positive Breast Cancer
08/26
08/26
NCT03614949: SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Active, not recruiting
2
21
US
Stereotactic body radiation therapy (SBRT), radiotherapy, Atezolizumab, Tecentriq®, immunotherapy
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
Cervical Cancer, Cervical Cancer Recurrent, Cervical Cancer Metastatic
10/25
10/26
NCT05528133: Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Recruiting
2
86
US
Genomically Guided Radiation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Triple Negative Breast Cancer
01/26
01/27
NCT04588545: Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Recruiting
1/2
39
US
Radiation Therapy, Pertuzumab, Trastuzumab
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease
07/25
07/25
MCC-21676, NCT06238921: Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

Recruiting
1/2
31
US
Stereotactic Radiation, Zimberelimab, Sacituzumab govitecan, Trodelvy
H. Lee Moffitt Cancer Center and Research Institute, Gilead Sciences
Breast Cancer, Triple Negative Breast Cancer
02/27
02/27
MCC-20899, NCT04923542: Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

Recruiting
1/2
31
US
Stereotactic Radiosurgery (SRS), Abemaciclib, Verzenio, Ramiven, Endocrine therapy, hormone therapy
H. Lee Moffitt Cancer Center and Research Institute, Eli Lilly and Company
Brain Metastases, HR+ Metastatic Breast Cancer
03/25
03/26
CA209-8NK, NCT03807765: Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

Active, not recruiting
1
14
US
Nivolumab, Opdivo, Stereotactic Radiosurgery
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb
Metastatic Breast Cancer, Brain Metastases
09/20
09/25
MIND-P, NCT04647474: Mental Wellbeing and Quality of Life in Prostate Cancer

Completed
N/A
300
Europe
King's College London, King's College Hospital NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Imperial College Healthcare NHS Trust, Medway NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Surrey and Sussex Healthcare NHS Trust, Bedfordshire Hospitals NHS Foundation Trust
Prostate Cancer
03/23
03/23

Download Options